(Q48761873)

15 February 2018

title

Critical oncogenic mutations in newly diagnosed pediatric diffuse intrinsic pontine glioma. (English)

1 reference

15 February 2018

main subject

diffuse midline glioma

0 references

author

Mark W. Kieran

6

1 reference

15 February 2018

Jacques Grill

1

object named as

Jacques Grill

1 reference

15 February 2018

Stephanie Puget

2

1 reference

15 February 2018

Felipe Andreiuolo

3

1 reference

15 February 2018

Cathy Philippe

4

1 reference

15 February 2018

Laura MacConaill

5

1 reference

15 February 2018

publication date

20 December 2011

1 reference

15 February 2018

published in

Pediatric Blood Cancer

1 reference

15 February 2018

volume

58

1 reference

15 February 2018

issue

4

1 reference

15 February 2018

page(s)

489-491

1 reference

15 February 2018

Diffuse intrinsic pontine glioma-current status and future strategies

cites work

1 reference

Treatment of diffuse intrinsic brainstem gliomas: failed approaches and future strategies

21 January 2018

1 reference

Homozygous loss of ADAM3A revealed by genome-wide analysis of pediatric high-grade glioma and diffuse intrinsic pontine gliomas

21 January 2018

1 reference

Whole-genome profiling of pediatric diffuse intrinsic pontine gliomas highlights platelet-derived growth factor receptor alpha and poly (ADP-ribose) polymerase as potential therapeutic targets

21 January 2018

1 reference

Molecular profiling identifies prognostic subgroups of pediatric glioblastoma and shows increased YB-1 expression in tumors.

21 January 2018

1 reference

Genome-wide analyses identify recurrent amplifications of receptor tyrosine kinases and cell-cycle regulatory genes in diffuse intrinsic pontine glioma

21 January 2018

1 reference

Profiling critical cancer gene mutations in clinical tumor samples

21 January 2018

1 reference

Target-driven exploratory study of imatinib mesylate in children with solid malignancies by the Innovative Therapies for Children with Cancer (ITCC) European Consortium.

21 January 2018

1 reference

Innovative Therapies for Children with Cancer pediatric phase I study of erlotinib in brainstem glioma and relapsing/refractory brain tumors

21 January 2018

1 reference

Clinical implications of the cancer genome

21 January 2018

1 reference

Recurrent BRAF mutations in Langerhans cell histiocytosis

21 January 2018

1 reference

Cancer-derived p53 mutants suppress p53-target gene expression--potential mechanism for gain of function of mutant p53.

21 January 2018

1 reference

Selective BRAFV600E inhibitor PLX4720, requires TRAIL assistance to overcome oncogenic PIK3CA resistance

21 January 2018

1 reference

PIK3CA mutations frequently coexist with RAS and BRAF mutations in patients with advanced cancers

21 January 2018

1 reference

Effects of clinically relevant MPL mutations in the transmembrane domain revealed at the atomic level through computational modeling

21 January 2018

1 reference

High-throughput oncogene mutation profiling in human cancer

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1002/PBC.24060

1 reference

15 February 2018

1 reference

15 February 2018